Go Deep
PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 19,798 | -9.8 | 3.20 | 0.23 | 1,818.96 |
| Oct 2026 | 20,140 | -9.0 | 2.93 | 0.23 | 1,662.53 |
| Oct 2026 | 20,001 | -10.2 | 3.04 | 0.23 | 1,723.54 |
| Oct 2026 | 20,127 | -9.1 | 2.94 | 0.23 | 1,664.14 |
| Oct 2026 | 19,974 | -9.4 | 3.06 | 0.23 | 1,733.24 |
| Oct 2026 | 19,858 | -9.7 | 3.15 | 0.23 | 1,784.44 |
| Oct 2026 | 19,976 | -9.4 | 3.06 | 0.23 | 1,728.02 |
| Oct 2026 | 19,597 | -10.3 | 3.35 | 0.23 | 1,890.65 |
| Oct 2026 | 19,612 | -10.3 | 3.34 | 0.23 | 1,891.85 |
PROCEPT BioRobotics Corporation Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 94,498,000.0 | 83,132,000.0 | 76,383,000.0 | 83,327,000.0 |
| Net Profit | -26,861,000.0 | -31,638,000.0 | -29,845,000.0 | -21,411,000.0 |
| EPS | -0.5 | -0.6 | -0.5 | -0.4 |
PROCEPT BioRobotics Corporation Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 308,054,000.0 | 224,498,000.0 | 136,191,000.0 | 75,014,000.0 | — |
| Net Profit | -95,572,000.0 | -91,413,000.0 | -105,897,000.0 | -87,154,000.0 | — |
| EPS | -1.7 | -1.8 | -2.2 | -2.0 | — |
PROCEPT BioRobotics Corporation Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 508,081,000.0 | 534,017,000.0 | 404,717,000.0 | 309,329,000.0 | — |
| Total Liabilities | 142,211,000.0 | 131,797,000.0 | 123,965,000.0 | 112,257,000.0 | — |
| Total Equity | 365,870,000.0 | 402,220,000.0 | 280,752,000.0 | 197,072,000.0 | — |
Owes vs Owns
PROCEPT BioRobotics Corporation owed $0.29 for every $1 it owned in Jun 2026, down from $0.36 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.29× | 0.28× | 0.25× | 0.31× | 0.36× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
PROCEPT BioRobotics Corporation Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 56.4%Receivables 16.4%Inventory 13.9%Fixed assets (tangible) 9.4%Other assets 3.7%
How it's funded — Dec 2025
Long-term debt 10.2%Payables 3.4%Other liabilities 14.0%Shareholders' equity 72.0%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 286.5 | 333.7 | 257.2 | 221.9 |
| Receivables | 83.5 | 83.5 | 48.4 | 15.3 |
| Inventory | 70.7 | 56.2 | 39.8 | 28.5 |
| Fixed assets (tangible) | 47.9 | 45.6 | 49.0 | 32.1 |
| Intangible assets | 0.7 | 0.9 | 1.2 | 1.5 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 18.7 | 14.0 | 9.2 | 10.0 |
| Liabilities & equity | ||||
| Short-term debt | 2.2 | 1.9 | 1.7 | 2.1 |
| Long-term debt | 51.6 | 51.5 | 51.3 | 51.2 |
| Payables | 17.3 | 10.0 | 13.5 | 9.4 |
| Other liabilities | 71.1 | 68.4 | 57.4 | 49.5 |
| Shareholders' equity | 365.9 | 402.2 | 280.8 | 197.1 |
| Net tangible assets | 365.2 | 401.3 | 279.5 | 195.6 |
PROCEPT BioRobotics Corporation Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -48,985,000.0 | -99,213,000.0 | -108,003,000.0 | -80,382,000.0 | — |
| Investing Activities | -9,356,000.0 | -4,409,000.0 | -25,206,000.0 | -2,653,000.0 | — |
| Financing Activities | 11,193,000.0 | 180,125,000.0 | 167,795,000.0 | 3,612,000.0 | — |